Among these molecules, IGF-1 and IGF-2 have been shown to be released by epithelial BC cells and drive the acquisition of the activated status in adjacent fibroblasts, toward increased migratory and invasive behavior (De Vincenzo et al., 2019). Here, IGF1 is linked to breast cancer.